Valeant Probe Reprises Federal Focus on Drug Pricing

Drug pricing, a key issue in the federal investigation of Valeant Pharmaceuticals International, has been a frequent of federal prosecutions and whistleblower lawsuits in recent years.

from WSJ.com: US Business http://ift.tt/1OGCt0M
via IFTTT